GlassScriptPhysician profile
Erwin M Omens
NPI 1477519205
$3,398.45
in general payments reported to CMS, 2019-2025
17 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,310 · 2020: $184 · 2021: $831 · 2022: $288 · 2023: $604 · 2024: $56.12 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $786.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $785.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $788.46 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $595.03 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $394.13 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $261.62 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $249.31 | 2023 | Miebo |
| Apellis Pharmaceuticals, INC. | $235.17 | 2023 | Syfovre |
| Abbvie INC. | $166.56 | 2022-2025 | |
| Kala Pharmaceuticals, INC. | $142.89 | 2019 | |
| Shire North American Group INC | $123.88 | 2019 | |
| Beaver-Visitec International, INC. | $119.98 | 2023 | |
| Oyster Point Pharma, INC. | $98.29 | 2022 | |
| Eyepoint US, INC. | $82.39 | 2021 | |
| Alcon Vision LLC | $50.77 | 2019-2022 | |
| Thea Pharma INC. | $40.32 | 2022-2024 | Iyuzeh |
| Novartis Pharmaceuticals Corporation | $19.18 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recordati_rare_diseases_inc. | $16.21 | 2024 | Cystadrops |
| Ocular Therapeutix, INC. | $14.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erwin Omens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.